No Data
No Data
Shanxi Zhendong Pharmaceutical Co.,Ltd's (SZSE:300158) Share Price Is Matching Sentiment Around Its Revenues
Shanxi Zhendong Pharmaceutical (300158.SZ): has cumulatively repurchased 0.29% of shares.
On February 6, Gelonghui reported that Shanxi Zhendong Pharmaceutical (300158.SZ) announced that as of January 31, 2025, the company has cumulatively repurchased 2,965,600 shares through a dedicated securities repurchase account using centralized bidding methods, accounting for 0.29% of the company's total share capital. The highest Fill Price repurchased was 5.03 yuan per share, the lowest Fill Price was 3.76 yuan per share, and the total amount spent on repurchases was 11.874695 million yuan (excluding trading fees).
Zhendong Pharmaceutical: 2024 Annual Results Forecast
Shanxi Zhendong Pharmaceutical Co.,Ltd's (SZSE:300158) Stock Price Dropped 11% Last Week; Individual Investors Would Not Be Happy
The seasonal influenza A has entered the epidemic period, and the sales of related Chinese Patent Medicine products have significantly increased.
① Recently, the positive rate of influenza virus has significantly increased, with over 99% being type A influenza. Market data shows a clear increase in the demand for various Traditional Chinese Medicine cold medicine products. ② Today, stock prices of several listed companies in the Traditional Chinese Medicine Industry, such as Shanxi Zhendong Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Zhongsheng Pharmaceutical, have reached the daily limit, with the Traditional Chinese Medicine Sector overall rising, and the Traditional Chinese Medicine 50 ETF increasing by 3.21%.
Shanxi Zhendong PharmaceuticalLtd (SZSE:300158) Is In A Good Position To Deliver On Growth Plans